|
||||
| Reader Comments | ||||
| guest on Monday, June 2, 2008 at 4:32:19 pm The points taken in this posting are well founded and appropriate. The pharmaceutical companies have provided benefit to consumers. Dietitians have done yeoman work in the field of nutrition. Many of us in the industry gratefully acknowledge this work. Here is the rub in this specific instance. The coverage of the petition by the "beard" of the dietitians should be better recognized as such. The benefactor, not clearly identified as such, is GSK. Assessment of the effort would likely reveal that the bulk of the funding came from GSK. The petition is very well done and this posting does not address the flaws only the vested interest that does exist. GSK makes a product called Alli. They have a distinct and most vested interest in the success of this petition. Why? Because it corners the market on weight loss adjuncts. Omission of this material fact is not a crime, it is merely an omission. However it is a glaring one. Using the government to further one's specific agenda (i.e. capturing an entire market) is somehow inappropriate. While the efforts of the companies and entities involved with the petition are laudable, the concept, funding and de facto purpose of the petition are not. I venture to say that it is less a matter of the desired outcome than it is the method used to achieve the outcome. You will be seeing, from private company quarters, notable response to this petition. Some of these will talk of the warts both pharma and the dietary supplement industry has while discussing the merits of both sides of the petition's argument. There is much we can learn from one another -- we do need to insure that we keep the knowledge exchange honest and open. | ||||
| guest on Monday, June 2, 2008 at 4:16:15 pm I welcome the pharma community. However the GlaxoSmithKline petition is trying to curb the scope of competition by changing the vocabulary. GlaxoSmithKline will limit the number of professionals commited to helping people in fact GlaxoSmithKline method is going to make the situation worse, people will believe a single pill will fix there obesity issues when verses learning how to eat. In our socity the quick fix is the answer and GlaxoSmithKline is jumping on the band wagon. | ||||
| guest on Monday, June 2, 2008 at 3:24:57 pm Excellent statement reminding us that pharmaceutical grade nutrients are supplied by the pharmaceutical industry. However, that same industry does not seem to share as its primary goal helping people lead healthier, quality lives. One need only consider the overall statistics of illness produced by over prescribing of drugs and even further the pharmaceutical industries are the producers of toxic chemicals, genetically modified food products and advocates of food irradiation. These industries have a greater goal towards profits at any cost with very harmful results. It is shameful the number of people on prescriptive medicines and their manipulated direction away from safe and affordable nutritional alternatives. I think it is time for the pharmaceutical industry to embrace our position and use their great talents to achieve a healthy United States and not one that is reaching its nadir in its health standings within the world. I recently met with an owner of an Ayurvedic compnay who previously owned a major pharmaceutical manufacturing company of antibiotics in India. He sold the company and then fell ill. He was introduced to Ayurvedic medicine and soon began researching the field and comparing notes with his experience from his previous company. His intelligent approach and deep scientific background lent itself well to the kind of engagement that Craig Maltby suggests resulting in an excellent Ayurvedic company that, though new, has superior natural products to offer people to regain and maintain health. | ||||
Blog Archives | Send this page to a Friend
